Hot Products
Case
By selecting high-quality raw materials and combining them with advanced technology, we create efficient, safe, and sustainable chemical solutions to help our customers stay ahead of the competition.
About Us
Global Technology Co., Ltd is a modern advanced enterprise specializing in production and exportation of APIs, peptides, plant extracts etc., has invested and closed cooperated with domestic manufacturers qualified with GMP, DMF, FDA and Laboratories from famous Universities to meet the different customers needs from grams to tonnage quantity, which makes Dejuru Pharmaceutical to be more flexible and easily to supply highly cost-effective products with high quality and better service to customers.
Advantage
We focus on the research and supply of high-quality chemicals, strictly following international standards and quality systems. Our products have stable performance and reliable purity, and are widely used in industrial manufacturing, scientific research experiments, and fine chemical industries. Provide solid support for every process with professionalism and responsibility
High-end Product Technical Barriers
Deeply cultivating high-value-added categories This has broken the monopoly of European and American companies in the high-end pharmaceutical intermediates sector, establishing us as the exclusive Asian supplier for giants like Pfizer and Merck.
Global Multi-System Certification Coverage
Products fully comply with USP (United States Pharmacopeia), BP (British Pharmacopoeia), and EP (European Pharmacopoeia) standards.
Customized Logistics Solutions
Tailored to pharmaceutical intermediates, we established multimodal logistics channels including sea-air multimodal transport, dedicated cold chain routes, and cross-border railways.
Leading Client Ecosystem
Long-term service provider to global pharmaceutical industry leaders including Pfizer, Merck, Sun Pharmaceutical, LG Chem, and 3M.
Our Blog
Adhere to safety production and green concepts, strictly control production processes and environmental indicators, and strive to provide customers with safer and more environmentally friendly chemical products.
High Purity Neurotensin Analogs and Exemestane Class Probes
Jul 06, 26
The pharmaceutical landscape is constantly evolving, with a significant focus on the development of highly specific ligands to decode complex biological systems. Within this context, the study of the exemestane class of research toolsspecifically high-purity peptide analogsplays a pivotal role in understanding receptor-mediated signaling. By utilizing precise molecular modifications, researchers can now probe the intricacies of the neurotensin system with unprecedented accuracy. Globally, the demand for specialized research probes has surged as medicinal chemistry shifts toward rational drug design. The ability to modulate binding affinity and selectivity between receptor subtypes is no longer a luxury but a necessity
Read More
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
Jul 03, 26
The landscape of biochemical analysis has been significantly transformed by the introduction of high-precision substrates, a field where the concept of exemestane 25 mg bodybuilding often appears in search queries despite the stark difference between clinical aromataze inhibitors and laboratory reagents. In the realm of pharmaceutical manufacturing and food science, the ability to quantify protease activity with absolute precision is paramount for maintaining product stability and quality. Understanding the mechanism of chromogenic substrates allows researchers to bridge the gap between raw biochemical data and commercial application.
Read More
Understanding the Therapeutic Role of exemestane drug class
Jul 01, 26
Understanding the Exemestane Drug Class and Its Therapeutic Role In the realm of endocrine therapy for breast cancer, identifying the correct exemestane drug class is critical for optimizing patient outcomes. Exemestane belongs to a specialized group of medications designed to inhibit the production of estrogen, which fuels the growth of hormone-receptor-positive breast cancers. Unlike earlier generations of hormone therapies, this class offers a more direct approach to enzymatic inhibition. By targeting the final step of estrogen synthesis, it provides a robust mechanism for managing postmenopausal oncology cases. Understanding the nuances of this pharmacological category allows researchers and clinicians to better navigate
Read More